Founded by Pete Young, one of the few original marijuana activists, INDIVA comes from a rich history and deep roots of fighting for the right to use cannabis as medicine. Pete’s journey started back in the 1980’s and now, his company is licensed to produce cannabis legally by the Canadian federal government.
INDIVA (TSXV-NVDA) – Volume 022
INDIVA was founded by the activist and passion Pete Young, a well-recognized cannabis activist and winner of multiple industry awards. In his early days, Pete joined Hemp Nation, a cannabis activist group. Hemp Nation was the first public group to challenge the unconstitutional banning of cannabis. His challenge was rejected by the fed in 1996.
The London Compassion Society was launched in 2000 as a non-profit organization by Pete. The organization runs a spa, wellness center, and educational resources for people seeking reliable, expert information about medical cannabis.
In 2010, The London Compassion Society evolved into INDIVA in order to comply with the new regulations imposed by the Canadian Government to shift cannabis supply away from black market producers. In 2014, the company became a licensed producer of medical cannabis and began construction of its first garden in London, Ontario, has an area of about 10,000 square feet.
The Company has plans in place to expand its existing facility by 26,000 square feet in order to provide more room for growing and cultivation. The company’s headquarters are in Ottawa, Canada. INDIVA is a wholly owned subsidiary of Rainmaker resources limited.
Niel Marotta – President, CEO, Director, Founder
Neil has extensive experience in investment banking, participating in significant financial transactions. His portfolio as a fund manager is vast, accumulating over $1 billion in financials over various industries. He has also worked in the natural resource industry in a TSX listed company, acting as Vice President.
Koby Smutylo – Founder, Director, Legal & Business Development,
Koby is a seasoned lawyer with experience in starting and running his own business law firm in Ottawa. He has also acted as a lawyer for both private and public companies, recently representing an ACMPR cannabis producer in its successful bid to acquire a license from Health Canada.
Jennifer Welsh – CFO
Jennifer is a registered financial accountant, with vast experience working in the corporate and global finance sectors. She also has pre-existing interaction with the medical cannabis industry, offering her services to a Licensed Producer.
INDIVA Location and Facilities
In 2017, the Company completed the implementation of its state-of-the-art cultivation center in Ontario, along with Canada’s largest highway. The facility incorporates modern agriculture technologies, sustainable growing practices, and high-quality genetic materials to produce high-quality cannabis consistently to its customers.
The Company also received $15 million equity financing, part of which will be utilized to further expand its existing facilities by an additional 26,000 square feet. The new facilities will comprise a total of 36,000 square feet, with 23,000 square feet being devoted to growth space.
In September 2013, Health Canada received a license application for the production, distribution, and sale of medical cannabis from INDIVA under the Access to Cannabis for Medical Purposes Regulations (ACMPR). In March 2017, INDIVA received it Pre-License inspection Letter and applied for inspection by Health Canada officials two months later.
INDIVA is currently producing its first ever cannabis for sale to its patients. The Company has opened pre-registration and is welcoming new patients.
The main products of INDIVA will consist of medicinal cannabis products, which are obtained through a refined process of specially-selected strains. The medicinal products are classified into sativas, indicas, hybrids and high-CBD strains, which serve an array of customer requirements and needs.
INDIVA also produces dried cannabis flowers for sale, as the most popular form of cannabis due to its versatility and fast-acting effects. The company offers instruction on the use of these products so as to prevent overmedication.
Medical cannabis oils and extracts are another diversification product of INDIVA . These are concentrates containing a high level of cannabinoids, making medical cannabis more effective. Due to their high concentration, small doses are required for medication. The oils are usually vaporized and inhaled, to optimize their effectiveness. INDIVA provides the customer with a vaporizing pen for discreet and measured application of the oils.
INDIVA also plans to produce safe edibles and other client-friendly cannabis products due to the increasingly liberal laws and regulations regarding cannabis usage in Canada.
Subsidiaries and Partnerships
Rainmaker resources limited
On June 1st, 2017, INDIVA signed a binding letter of Intent with Rainmaker Resources Limited, as a way to obtain its Cultivation License pursuant to Health Canada’s Access to Cannabis for Medical Purposes Regulations. The shares of INDIVA were transferred to Rainmaker Resources Limited, making INDIVA a wholly-owned subsidiary.
Medropharm GmbH and Greenfields Health Care S.A. – Licensors
On December 21st, 2017, INDIVA entered into a strategic cooperation agreement with the licensors above for the exclusive supply of multiple premium cannabis strains by the aforementioned licensors for cultivation and sale by INDIVA in Canada. The agreement grants the company exclusive rights to import, cultivate and sell three high-CBD, low-THC strains of cannabis, with the licensors identifying the optimal uses of the provided strains, as well as the most effective cultivation techniques.